Emerald Mutual Fund Advisers Trust Acquires New Stake in Omada Health, Inc. $OMDA

Emerald Mutual Fund Advisers Trust acquired a new stake in Omada Health, Inc. (NASDAQ:OMDA) during the second quarter, HoldingsChannel reports. The fund acquired 161,227 shares of the company’s stock, valued at approximately $2,950,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Sanofi purchased a new position in Omada Health in the 2nd quarter valued at $9,606,000. Emerald Advisers LLC acquired a new stake in Omada Health in the second quarter valued at $5,089,000. Jennison Associates LLC acquired a new stake in Omada Health in the second quarter valued at $4,580,000. Finally, Teacher Retirement System of Texas acquired a new stake in Omada Health in the second quarter valued at $640,000.

Analysts Set New Price Targets

A number of research firms have commented on OMDA. Needham & Company LLC raised their target price on Omada Health from $23.00 to $24.00 and gave the company a “buy” rating in a report on Friday, August 8th. Robert W. Baird began coverage on Omada Health in a report on Friday, September 5th. They issued a “neutral” rating and a $24.00 target price for the company. Weiss Ratings reissued a “sell (d)” rating on shares of Omada Health in a report on Wednesday, October 8th. Canaccord Genuity Group raised their target price on Omada Health from $27.00 to $28.00 and gave the company a “buy” rating in a report on Friday, August 8th. Finally, Evercore ISI set a $27.00 target price on Omada Health in a report on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $25.50.

Omada Health Price Performance

NASDAQ:OMDA opened at $25.20 on Thursday. Omada Health, Inc. has a 52-week low of $14.14 and a 52-week high of $28.40. The stock’s fifty day moving average price is $23.52.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.07). The firm had revenue of $61.37 million during the quarter, compared to analyst estimates of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

About Omada Health

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.